Bladder CancerExams and TestsTo determine whether
bladder cancer may be the cause of your urinary
symptoms, your health professional will evaluate your: - Physical symptoms. A physical exam may include
a
rectal exam, a
prostate exam for men, or a
pelvic exam for women.
- Medical history,
including your smoking history and your possible exposure to cancer-causing
chemicals.
- Family history of cancer.
- A
urine test and
urine culture, to determine the presence of blood,
infection, and other abnormal cells.
Initial diagnostic tests will include a
cystoscopy, a test that allows your doctor to look at
your bladder with a thin lighted scope (cytoscope). Small tissue samples (biopsies) of any abnormal areas are taken and looked
at under a microscope to determine whether cancer cells are present and what
the cells look like (grade). Information from the biopsy, cytoscopy, and
sometimes other tests is used to determine the size and extent of the cancer
(stage). Cancer stage and grade tell the size and shape
of cancer cells and whether they have spread to other body areas. Knowing the
stage and grade helps you and your doctor make treatment decisions. Other diagnostic tests that may be done include: If bladder cancer is diagnosed, more tests may be needed to
determine whether the cancer has spread (metastasized). - A
CT scan or
MRI may be done to determine whether the cancer has
spread to lymph nodes, the lungs, the liver, or other abdominal organs.
- A
chest X-ray may be done to determine whether the
cancer has spread to the lungs.
- A
barium enema or
colonoscopy may be done to determine whether the
cancer involves the intestines.
- A
bone scan may be done to determine whether the cancer
has spread to the bones.
Early detection of returning cancerAfter you have been treated for bladder cancer, it is important
to have regular examinations and
cystoscopies to detect any recurrence early so that
additional treatment can begin immediately. Researchers are studying ways to
identify low-grade cancer cells without the need for a cystoscopy. Some tests
for specific proteins in cancer cells (tumor markers), such as BTA and NMP22,
have been approved by the U.S. Food and Drug Administration (FDA) to use to
detect recurrent cancer.8 More research is being done
on these screening methods because they are not as accurate as a cystoscopy at
this time.9
| |